Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-08 Sale | 2024-03-13 06:04 am | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 29,491 | $26.59 | $784,248 | 156,800 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:56 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,591 | $25.85 | $41,127 | 186,291 (Direct) | View |
| 2023-12-11 Sale | 2023-12-12 5:34 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,616 | $10.72 | $17,324 | 187,882 (Direct) | View |
| 2023-11-02 Sale | 2023-11-02 5:16 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 9,939 | $7.4 | $73,549 | 94,605 (Direct) | View |
| 2023-09-18 Sale | 2023-09-20 4:48 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 2,672 | $9.41 | $25,144 | 104,544 (Direct) | View |
| 2023-09-12 Sale | 2023-09-13 7:51 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,635 | $10.41 | $17,020 | 107,216 (Direct) | View |
| 2023-06-13 Sale | 2023-06-14 6:40 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,625 | $12.43 | $20,199 | 108,851 (Direct) | View |
| 2023-03-14 Sale | 2023-03-15 5:50 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,559 | $13.33 | $20,781 | 110,476 (Direct) | View |
| 2022-12-12 Sale | 2022-12-13 5:05 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 751 | $10.87 | $8,163 | 181,035 (Direct) | View |
| 2022-03-11 Sale | 2022-03-14 5:08 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 765 | $8.73 | $6,678 | 73,003 (Direct) | View |
| 2021-09-23 Sale | 2021-09-24 10:50 am | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 2,451 | $17.22 | $42,206 | 33,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-15 Option Award | 2023-11-16 4:30 pm | N/A 2033-11-14 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 131,845 | $0 | 226,450 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 5:05 pm | N/A 2032-12-08 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 113,000 | $0 | 181,035 (Direct) | View |
| 2022-09-20 Disposition | 2022-09-21 4:08 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 2,629 | $13.7 | 68,786 (Direct) | View |
| 2022-09-15 Disposition | 2022-09-15 5:26 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 786 | $14.05 | 71,415 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 6:19 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 36,219 | $0 | 36,219 (Direct) | View |
| 2022-06-14 Disposition | 2022-06-15 8:03 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 802 | $4.95 | 72,201 (Direct) | View |
| 2021-12-10 Option Award | 2021-12-14 4:21 pm | N/A 2031-12-09 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 100,787 | $0 | 134,240 (Direct) | View |
| 2020-09-16 Option Award | 2020-09-18 5:16 pm | N/A 2030-09-15 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 147,309 | $0 | 147,309 (Direct) | View |
Ownership | 2020-09-17 6:25 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 0 | $0 | 329,143 (Direct) | View |